[{"title": "Cardiac events and dynamic echocardiographic and electrocardiogram changes following osimertinib treatment in lung cancer", "link": "https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2024.1485033/pdf", "details": "JN Le, JO Gasho, O Peony, A Singh, KD Silos, S Kim\u2026 - Frontiers in Cardiovascular \u2026, 2024", "abstract": "Osimertinib is first-line treatment for epidermal growth factor (EGFR)-mutated non- small cell lung cancer (NSCLC) and has been associated with cardiotoxicity. However, the nature of cardiac remodeling and associated risk factors remains \u2026"}]
